A New Look at Cirrhosis

Overview

Journal J R Coll Physicians Lond

Specialty General Medicine

Date 1982 Jan 1

PMID 7038110

Authors

T W Warnes

Affiliations

Soon will be listed here.

References

Scott J, Long R, Dick R, Sherlock S . Proceedings: Percutaneous, transhepatic catheterization and sclerosis of bleeding varices. Gut. 1976; 17(5):390. View

Bailey R, Krasner N, Eddleston A, Williams R, TEE D, Doniach D . Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J. 1976; 2(6038):727-9. PMC: 1688772. DOI: 10.1136/bmj.2.6038.727. View

Melendez M, Fuentes C, Castillo D, Wolff C, Wegmann M, Soto J . Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease. Gut. 1979; 20(4):288-90. PMC: 1412391. DOI: 10.1136/gut.20.4.288. View

Larusso N, Summerskill W, McCALL J . Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology. 1976; 70(5 PT.1):653-5. View

Ercilla G, Pares A, Arriaga F, Bruguera M, Castillo R, Rodes J . Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 1979; 14(5):449-52. DOI: 10.1111/j.1399-0039.1979.tb00874.x. View

Simon M, BOUREL M, Fauchet R, GENETET B . Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut. 1976; 17(5):332-4. PMC: 1411133. DOI: 10.1136/gut.17.5.332. View

UZMAN L, Iber F, CHALMERS T . The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease). Am J Med Sci. 1956; 231(5):511-8. DOI: 10.1097/00000441-195605000-00004. View

Leevy C, Zinke M, Baber J, Chey W . Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis. Ann Intern Med. 1958; 49(4):837-51. DOI: 10.7326/0003-4819-49-4-837. View

Cameron R, Bunton G . Congenital biliary atresia. Br Med J. 1960; 2(5208):1253-7. PMC: 2097045. DOI: 10.1136/bmj.2.5208.1253. View

10.

Schaffner F, POPER H . Capillarization of hepatic sinusoids in man. Gastroenterology. 1963; 44:239-42. View

11.

Tygstrup N . THE GALACTOSE ELIMINATION CAPACITY IN CONTROL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS OF THE LIVER. Acta Med Scand. 1964; 175:281-9. DOI: 10.1111/j.0954-6820.1964.tb00576.x. View

12.

Paronetto F, Schaffner F, Popper H . IMMUNOCYTOCHEMICAL AND SEROLOGIC OBSERVATIONS IN PRIMARY BILIARY CIRRHOSIS. N Engl J Med. 1964; 271:1123-8. DOI: 10.1056/NEJM196411262712201. View

13.

HALES M, Allan J, Hall E . Injection-corrosion studies of normal and cirrhotic livers. Am J Pathol. 1959; 35:909-41. PMC: 1934843. View

14.

Popper H, Elias H, PETTY D . Vascular pattern of the cirrhotic liver. Am J Clin Pathol. 1952; 22(8):717-29. DOI: 10.1093/ajcp/22.8.717. View

15.

Cochrane A, Moussouros A, Portmann B, McFarlane I, Thomson A, Eddleston . Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology. 1977; 72(5 Pt 1):918-23. View

16.

Maddrey W, Boitnott J, Bedine M, Weber Jr F, Mezey E, White Jr R . Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978; 75(2):193-9. View

17.

Terblanche J, Northover J, Bornman P, Kahn D, SILBER W, Barbezat G . A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet. 1979; 148(3):323-33. View

18.

Kershenobich D, Uribe M, Suarez G, Mata J, Perez-Tamayo R, Rojkind M . Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology. 1979; 77(3):532-6. View

19.

Bulkley B, GOLDFINGER S, Heizer W, Isselbacher K, Shulman N . Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970; 2(7687):1323-6. DOI: 10.1016/s0140-6736(70)92356-1. View

20.

Murray-Lyon I, Stern R, Williams R . Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973; 1(7806):735-7. DOI: 10.1016/s0140-6736(73)92125-9. View